Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
Do good work, have integrity, listen to frontline employees.
By
A simple lesson from Starbucks on how to introduce new technology into the workplace.
By
A new MIT report says business has a role to play in determining what quality work will look like in a world remade by AI and robotics.
By
MIT Sloan research finds top-quartile investors ink better deals and record better returns. Other investors, not so much.
By
Jacklyn Dallas on time management, learning from feedback, and staying true to yourself.
By
What started as a compliance role is poised for growth as financial services embrace the power of data.
By
The companies will compete Nov. 21 in Cambridge, Massachusetts, for a piece of the MIT Inclusive Innovation Challenge $1 million grand prize.
By
Companies are investing in technology that replaces workers but brings little improvement to productivity. Here’s how to break the cycle.
By
Socially responsible investors are putting their money where their values are, which is good news for firms committed to tackling global problems.